Sublingual B12 raises blood numbers. It has never been shown to protect a single nerve. There is no reason to think it prevents permanent nerve damage.
Pernicious Anemia
PA and B12 Deficiency Run in Families
Pernicious anemia has documented familial prevalence. First-degree relatives of PA patients carry a risk four times higher than the general population, and among siblings the figure is higher still — roughly six times the baseline rate. This reflects shared genetic architecture that shapes immune function across generations. B12 deficiency more broadly also clusters in families … Read more
No Market, No Attention: Pernicious Anemia and the Cost of Invisibility
Pernicious anemia is one of the clearest cases in contemporary medicine where everything required for good outcomes exists — the diagnostic tools, the treatment, the evidence base — and the outcomes remain poor anyway. The gap between what medicine knows and what medicine does is not a gap in knowledge.
History and Misdiagnosis of Pernicious Anemia
How a 19th-Century Disease Model Still Shapes Modern Care Pernicious anemia has been misunderstood since it was first described. That misunderstanding did not persist because of a lack of scientific progress, but because early observations hardened into a disease model that medicine never fully revised. The result is a condition that remains misdiagnosed, underdiagnosed, and … Read more
Why Do I Feel Worse After Starting B12 Treatment?
Why Do I Feel Worse After Starting B12 Treatment?
After years of symptoms and possibly decades of misdiagnosis, starting B12 injections should bring relief. Sometimes, though, people feel worse instead of better. Tingling may increase, fatigue may deepen, or brain fog may seem thicker than before.
This temporary worsening often happens in the first few weeks of B12 treatment. It’s actually a sign that the body is beginning to heal. For many people, it feels like “two steps forward, one step back.”
B12 Beyond the Basics: Cellular Resistance and Functional Deficiencies
B12 Beyond the Basics: Pernicious Anemia, Cellular Resistance, and Functional Deficiencies
Introduction
Vitamin B12 is essential to DNA synthesis, red blood cell formation, neurological integrity, and methylation — the process by which the body converts homocysteine to methionine. Deficiency at any of these levels can produce serious and, if uncorrected, permanent damage: megaloblastic anemia, peripheral neuropathy, spinal cord degeneration, cognitive impairment, and psychiatric symptoms that are frequently misattributed to primary mental illness.
The problem facing both patients and clinicians is that B12-related illness is not a single condition with a single cause. Pernicious anemia (PA) — the best-known cause of B12 deficiency — results from an autoimmune failure of absorption. But a growing body of evidence describes a different category of B12-related illness in which absorption is intact and blood B12 levels appear normal, yet symptoms of deficiency persist. This second category, sometimes called B12 resistance or cellular resistance, reflects failures in transport, cellular uptake, or intracellular conversion after B12 has entered the bloodstream.
PA: 𝗗𝗲𝗽𝗿𝗲𝘀𝘀𝗶𝗼𝗻, 𝗔𝗻𝘅𝗶𝗲𝘁𝘆, 𝗮𝗻𝗱 𝗢𝘁𝗵𝗲𝗿 𝗣𝘀𝘆𝗰𝗵𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝗘𝗳𝗳𝗲𝗰𝘁𝘀
𝗗𝗲𝗽𝗿𝗲𝘀𝘀𝗶𝗼𝗻, 𝗔𝗻𝘅𝗶𝗲𝘁𝘆, 𝗮𝗻𝗱 𝗢𝘁𝗵𝗲𝗿 𝗣𝘀𝘆𝗰𝗵𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝗘𝗳𝗳𝗲𝗰𝘁𝘀
𝗜𝗻𝘁𝗿𝗼𝗱𝘂𝗰𝘁𝗶𝗼𝗻
Pernicious anemia often affects how a person feels, thinks, and emotionally regulates long before it is recognized as a vitamin B12 disorder.
People with pernicious anemia may experience persistent anxiety, low mood, emotional volatility, intrusive worry, difficulty concentrating, and a strong internal sense of physiological unease. Health-focused anxiety—ongoing concern about bodily sensations and symptoms—is a common expression of these changes.
These psychological effects arise from the way pernicious anemia impacts the nervous system.
Pernicious Anemia and Subacute Combined Degeneration
Pernicious Anemia Is a Neurological Disease
I. Pernicious Anemia Is a Demyelinating Neurological Disease
Pernicious anemia (PA) is an autoimmune disorder in which vitamin B12 cannot be adequately absorbed or utilized, leading to progressive neurological injury.
Autoimmune failure of vitamin B12 absorption disrupts methylation and fatty acid metabolism essential for myelin maintenance and repair, producing central and peripheral demyelination, tract-specific spinal cord injury (classically subacute combined degeneration), and widespread cognitive, emotional, and psychiatric manifestations. These neurological effects frequently precede anemia and may occur in its absence.
Pernicious anemia (PA) typically has an insidious onset, with early symptoms that are nonspecific and easily misattributed. As a result, diagnosis is often delayed several years from symptom onset to receive a correct diagnosis, and a substantial proportion are initially misdiagnosed or not diagnosed at all. During this period, neurological injury continues to accumulate. Clinicians are therefore often faced with patients who already have advanced neural involvement by the time the underlying disorder is recognized.
Because myelin repair is metabolically demanding and time-dependent, outcomes depend not only on correcting cellular B12 deficiency but on interacting system constraints rather than hematologic markers alone.
Understanding how this injury unfolds, and why its effects vary so widely, requires looking beyond any single pathway.
B12 Deficiency Across Pregnancy: A Continuous Exposure Timeline
Note: This outline is a work in progress. Most statements draw on the technical article in Reference 1; items marked “[ref needed]” indicate areas where I plan to add specific supporting studies in a later revision.
Core thesis: B12 deficiency creates a continuous risk window beginning before conception, extending through pregnancy and lactation, and surfacing months later in infants. Without recognition and treatment, this single deficiency causes neural tube defects, recurrent pregnancy loss, preeclampsia, gestational diabetes, infant neurologic crisis, and potentially permanent developmental and metabolic harm to both mother and child.1 Standard prenatal care—which universally supplements folic acid but rarely screens for B12—can mask the deficiency while neurologic damage progresses.1,2,3 Even when B12 supplementation occurs alongside folic acid, standard serum B12 testing cannot confirm adequate cellular uptake, as most circulating B12 is bound to metabolically inactive proteins rather than the transcobalamin required for tissue delivery.1
Pernicious Anemia: A History of Observation, Misdiagnosis, and Systemic Blind Spots
Pernicious Anemia: A History of Observation, Misdiagnosis, and Systemic Blind Spots
Pernicious anemia is often described as a rare autoimmune disease that causes vitamin B12 deficiency and anemia. That description is technically incomplete and historically misleading. The modern failures in diagnosis and treatment of pernicious anemia are not primarily due to lack of evidence or lack of effective therapy. They are the result of a long chain of observational bias, naming inertia, disciplinary silos, and systemic blind spots in medical education—particularly around nutrition and chronic disease.
To understand why pernicious anemia remains underdiagnosed and inadequately treated today, it is necessary to understand how the disease was first observed, how it was defined, and how those early definitions hardened into doctrine even as evidence changed.